Keyphrases
Lung Injury
100%
AE-IPF
100%
Desmosine
100%
Cystic Fibrosis
27%
Pulmonary Exacerbation
27%
Lung Function
18%
Airway
18%
Elastin
18%
Cystic Fibrosis Lung Disease
18%
Statistical Model
9%
Lung
9%
Structural Change
9%
Blood Samples
9%
Hospitalization
9%
Inflammatory Markers
9%
Inflammatory Mediators
9%
Urine Samples
9%
Radioimmunoassay
9%
Non-invasive Measurement
9%
Clinical Variables
9%
Breakdown Products
9%
Clinical Improvement
9%
Urinary Concentration
9%
Lung Parenchyma
9%
Matrix Components
9%
Spot Urine
9%
Structural Remodeling
9%
Functional Markers
9%
Average Length of Stay
9%
Concentration Function
9%
Multiple Time Points
9%
Lung Function Tests
9%
Specific Gravity
9%
Long-term Development
9%
Neutrophilic Inflammation
9%
Repeated Measures Modeling
9%
Short-term Damage
9%
Normalization Factor
9%
Acute Pulmonary Exacerbation
9%
Biochemistry, Genetics and Molecular Biology
Desmosine
100%
Cystic Fibrosis
100%
Elastin
18%
Mediator
9%
Urine Sampling
9%
Kidney Concentrating Capacity
9%